A new substrate is forming underneath every enterprise running AI agents at scale. OrgDrive is what it's called.
Across pharma R&D, financial services, and go-to-market, the same pattern keeps surfacing: the AI agents that actually produce outcomes aren't grounded in vector databases of raw documents. They're grounded in a curated, structured, living memory of what the firm knows.
About its customers. Its market. Its decisions. Its work.
The kind of knowledge that lives in people's heads and scattered slide decks today.
This is no longer a thesis. It's the conclusion enterprises are converging on, independently, after running AI in production long enough to know what doesn't work.
Searchable history is a feature. Compounding memory is a substrate.
The relationships. The decisions. The institutional pattern of how work actually gets done here. None of it can be bought from a vendor, scraped from the web, or reconstructed by a foundation model.
Every OrgDrive instance is structurally isolated. Signal Chunks accumulate inside the firm, for the firm. There is no cross-customer learning surface, no shared model fine-tuned on aggregated tenant data. Firm-sovereign means architecturally sovereign — not just contractually.
Satya Nadella named this asset at Davos: the defensible position in the AI era is firm-sovereign knowledge. The economics now back it empirically. Peer-reviewed studies in the American Economic Review and Journal of Political Economy have measured what happens when competing firms deploy AI on the same market signals: their systems converge — independently, without communication — on near-identical decisions. Harvard Business Review named the pattern in May 2026 and prescribed the answer: firms must encode proprietary signal their competitors cannot reconstruct.
That substrate is what OrgDrive is.
Build ceilings inverted. The workflow layer is commoditizing on schedule — internal teams with AI coding agents can replicate deterministic SaaS in weeks. But no coding agent can reconstruct the typed, contextual memory of how a specific firm has operated over time.
That's what makes this a moat, not a feature.
OrgDrive is the substrate. Applications built on it inherit the compounding properties of the memory beneath them — the longer the firm operates with the system, the harder the system is to displace.
Pharma R&D and financial services applications in design partnership. The substrate is the same. The verticals differ.
When memory becomes a substrate, the application built on it doesn't just run faster. The shape of the day inverts.
In OnePgr's first canonical pattern — AKU — a sales rep stops choosing which accounts to research and starts confirming a list the substrate has already prioritized overnight. Eighteen hours a week of admin collapses to four. The rep is no longer the producer of the work — the rep is the editor and closer. Forty accounts get worked at the cadence of eight.
This is what Brynjolfsson called the resolution of the Solow Paradox: the gains arrive not when the tool is bought, but when the organization rebuilds around it. The substrate is what makes the rebuild possible.
The same pattern is taking shape in pharma R&D, where the substrate captures what a molecule's progression meant across teams and decades, and in financial services, where the substrate encodes what each client relationship has revealed across cycles. The verticals differ. The shape — substrate beneath, new operating model on top — is the same.
Read the AKU memorandum →Building on this pattern, funding someone who is, or operating an enterprise that needs it?
Working with a small number of category-shaping investors and enterprise design partners. Pharma, financial services, GTM-led organizations.